These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23568520)

  • 1. CD44 targeting magnetic glyconanoparticles for atherosclerotic plaque imaging.
    El-Dakdouki MH; El-Boubbou K; Kamat M; Huang R; Abela GS; Kiupel M; Zhu DC; Huang X
    Pharm Res; 2014 Jun; 31(6):1426-37. PubMed ID: 23568520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Nanoprobe Morphology on Cellular Binding and Inflammatory Responses: Hyaluronan-Conjugated Magnetic Nanoworms for Magnetic Resonance Imaging of Atherosclerotic Plaques.
    Hossaini Nasr S; Tonson A; El-Dakdouki MH; Zhu DC; Agnew D; Wiseman R; Qian C; Huang X
    ACS Appl Mater Interfaces; 2018 Apr; 10(14):11495-11507. PubMed ID: 29558108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective atherosclerotic plaque inflammation inhibition with targeted drug delivery by hyaluronan conjugated atorvastatin nanoparticles.
    Hossaini Nasr S; Rashidijahanabad Z; Ramadan S; Kauffman N; Parameswaran N; Zinn KR; Qian C; Arora R; Agnew D; Huang X
    Nanoscale; 2020 May; 12(17):9541-9556. PubMed ID: 32314997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronan Nanoparticles Selectively Target Plaque-Associated Macrophages and Improve Plaque Stability in Atherosclerosis.
    Beldman TJ; Senders ML; Alaarg A; Pérez-Medina C; Tang J; Zhao Y; Fay F; Deichmöller J; Born B; Desclos E; van der Wel NN; Hoebe RA; Kohen F; Kartvelishvily E; Neeman M; Reiner T; Calcagno C; Fayad ZA; de Winther MPJ; Lutgens E; Mulder WJM; Kluza E
    ACS Nano; 2017 Jun; 11(6):5785-5799. PubMed ID: 28463501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying Vulnerable Atherosclerotic Plaque in Rabbits Using DMSA-USPIO Enhanced Magnetic Resonance Imaging to Investigate the Effect of Atorvastatin.
    Qi C; Deng L; Li D; Wu W; Gong L; Li Y; Zhang Q; Zhang T; Zhang C; Zhang Y
    PLoS One; 2015; 10(5):e0125677. PubMed ID: 25973795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plaque-hyaluronidase-responsive high-density-lipoprotein-mimetic nanoparticles for multistage intimal-macrophage-targeted drug delivery and enhanced anti-atherosclerotic therapy.
    Zhang M; He J; Jiang C; Zhang W; Yang Y; Wang Z; Liu J
    Int J Nanomedicine; 2017; 12():533-558. PubMed ID: 28144137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adiponectin-coated nanoparticles for enhanced imaging of atherosclerotic plaques.
    Almer G; Wernig K; Saba-Lepek M; Haj-Yahya S; Rattenberger J; Wagner J; Gradauer K; Frascione D; Pabst G; Leitinger G; Mangge H; Zimmer A; Prassl R
    Int J Nanomedicine; 2011; 6():1279-90. PubMed ID: 21753879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneal Macrophage-Specific TNF-α Gene Silencing in LPS-Induced Acute Inflammation Model Using CD44 Targeting Hyaluronic Acid Nanoparticles.
    Kosovrasti VY; Nechev LV; Amiji MM
    Mol Pharm; 2016 Oct; 13(10):3404-3416. PubMed ID: 27552547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a magnetic resonance imaging protocol for the characterization of atherosclerotic plaque by using vascular cell adhesion molecule-1 and apoptosis-targeted ultrasmall superparamagnetic iron oxide derivatives.
    Burtea C; Ballet S; Laurent S; Rousseaux O; Dencausse A; Gonzalez W; Port M; Corot C; Vander Elst L; Muller RN
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):e36-48. PubMed ID: 22516067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticles functionalised with an anti-platelet human antibody for in vivo detection of atherosclerotic plaque by magnetic resonance imaging.
    Jacobin-Valat MJ; Laroche-Traineau J; Larivière M; Mornet S; Sanchez S; Biran M; Lebaron C; Boudon J; Lacomme S; Cérutti M; Clofent-Sanchez G
    Nanomedicine; 2015 May; 11(4):927-37. PubMed ID: 25684334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collagen-specific peptide conjugated HDL nanoparticles as MRI contrast agent to evaluate compositional changes in atherosclerotic plaque regression.
    Chen W; Cormode DP; Vengrenyuk Y; Herranz B; Feig JE; Klink A; Mulder WJ; Fisher EA; Fayad ZA
    JACC Cardiovasc Imaging; 2013 Mar; 6(3):373-84. PubMed ID: 23433925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
    Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
    Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
    [No Abstract]   [Full Text] [Related]  

  • 13. In vivo detection of activated platelets allows characterizing rupture of atherosclerotic plaques with molecular magnetic resonance imaging in mice.
    von Elverfeldt D; von zur Muhlen C; Wiens K; Neudorfer I; Zirlik A; Meissner M; Tilly P; Charles AL; Bode C; Peter K; Fabre JE
    PLoS One; 2012; 7(9):e45008. PubMed ID: 23028736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasound/Optical Dual-Modality Imaging for Evaluation of Vulnerable Atherosclerotic Plaques with Osteopontin Targeted Nanoparticles.
    Li S; Gou T; Wang Q; Chen M; Chen Z; Xu M; Wang Y; Han D; Cao R; Liu J; Liang P; Dai Z; Cao F
    Macromol Biosci; 2020 Feb; 20(2):e1900279. PubMed ID: 31885210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging monocytes with iron oxide nanoparticles targeted towards the monocyte integrin MAC-1 (CD11b/CD18) does not result in improved atherosclerotic plaque detection by in vivo MRI.
    von zur Muhlen C; Fink-Petri A; Salaklang J; Paul D; Neudorfer I; Berti V; Merkle A; Peter K; Bode C; von Elverfeldt D
    Contrast Media Mol Imaging; 2010; 5(5):268-75. PubMed ID: 20973112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and cellular targets of the MRI contrast agent P947 for atherosclerosis imaging.
    Ouimet T; Lancelot E; Hyafil F; Rienzo M; Deux F; Lemaître M; Duquesnoy S; Garot J; Roques BP; Michel JB; Corot C; Ballet S
    Mol Pharm; 2012 Apr; 9(4):850-61. PubMed ID: 22352457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodality Imaging of Angiogenesis in a Rabbit Atherosclerotic Model by GEBP11 Peptide Targeted Nanoparticles.
    Su T; Wang YB; Han D; Wang J; Qi S; Gao L; Shao YH; Qiao HY; Chen JW; Liang SH; Nie YZ; Li JY; Cao F
    Theranostics; 2017; 7(19):4791-4804. PubMed ID: 29187904
    [No Abstract]   [Full Text] [Related]  

  • 18. Improved in vivo detection of atherosclerotic plaques with a tissue factor-targeting magnetic nanoprobe.
    Wei Q; Wang J; Shi W; Zhang B; Jiang H; Du M; Mei H; Hu Y
    Acta Biomater; 2019 May; 90():324-336. PubMed ID: 30954623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic mesoporous silica nanoparticles-aided dual MR/NIRF imaging to identify macrophage enrichment in atherosclerotic plaques.
    Wu M; Li X; Guo Q; Li J; Xu G; Li G; Wang J; Zhang X
    Nanomedicine; 2021 Feb; 32():102330. PubMed ID: 33171287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atherosclerotic plaque targeting mechanism of long-circulating nanoparticles established by multimodal imaging.
    Lobatto ME; Calcagno C; Millon A; Senders ML; Fay F; Robson PM; Ramachandran S; Binderup T; Paridaans MP; Sensarn S; Rogalla S; Gordon RE; Cardoso L; Storm G; Metselaar JM; Contag CH; Stroes ES; Fayad ZA; Mulder WJ
    ACS Nano; 2015 Feb; 9(2):1837-47. PubMed ID: 25619964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.